傲農生物(603363.SH):擬設福建傲芯種業、作為公司生豬育種核心業務的控股平台
格隆匯5月29日丨傲農生物(603363.SH)公佈,為了促進公司生豬育種板塊更專業、更高效地發展,增強公司生豬種業創新能力和水平,持續提升公司種豬產品質量、品牌和市場競爭力,公司擬在福建省漳州市投資設立福建傲芯種業科技有限公司(“目標公司”),目標公司成立後,公司擬將下屬生豬育種板塊部分子公司股權進行整合由目標公司持股,目標公司作為公司生豬育種核心業務的控股平台。目標公司註冊資本6億元,由公司認繳出資6億元,佔註冊資本比例100%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.